NAGE Q1 2026 Earnings Modest EPS Beat Amid Limited Revenue Disclosure UMBFO Q1 2026 Earnings Strong EPS Beat Signals Resilience Despite Revenue Disclosure Gap Enbridge Q1 2026 Earnings Earnings Beat Drives Modest Stock Gain Amid Stable Operations NKE Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Landscape PTHS Q1 2026 Earnings Narrowed Loss Per Share Beats Estimates No Revenue Yet Five9 Q1 2026 Earnings EPS Surges Past Estimates Stock Retreats Amid Market Uncertainty AGM Q1 2026 Earnings Strong EPS Beat Driven by Core Operations GBX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Stock Gain Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress COKE Q1 2026 Earnings Modest EPS Performance Amid Quiet Trading Amtech Systems Q1 2026 Earnings Strong Profitability Surprise Amid Revenue Discretion KSCP Q1 2026 Earnings Wider Loss Weighs on Sentiment as Stock Climbs